Anthem said on Friday it would buy Cigna in a deal valued at $54.2 billion, creating the largest U.S. health insurer.» Read More
In today's trading session, a total of 35 stocks in the S&P 500 reached new 52-week highs. Here is a look at those companies.
Futures mostly shrugged off news that weekly unemployment claims hit their lowest level in 15 months, but stocks were still poised for a gain in a holiday-shortened session Thursday.
President Barack Obama's health care overhaul cleared its second test in the Senate Tuesday. How is Washington action affecting stocks? Sheryl Skolnick, senior VP and health care analyst at Pali Capital, and Les Funtleyder, health care strategist at Miller Tabak, shared their insights.
The U.S. Senate is in the midst of debating a landmark plan to overhaul the health care system. Bruce Berkowitz, president of Fairholme Capital Management, says he's been increasing his exposure to the sector as a result.
The health care reform bill passed by the House this weekend now moves to the Senate, which has its own version of a bill. So how do investors play health care stocks? Les Funtleyder, health care strategist for Miller Tabak and Ipsita Smolinksi, health care analyst for Capitol Street gave their outlook on Monday to CNBC.
A late rally helped propel the Dow to a positive finish Monday as financial stocks rebounded.
Stocks erased all of their gains Monday after an early surge due to a better-than-expected manufacturing report. Financials led the decline.
The Dow shot up more than 100 points Monday after a report showed manufacturing expanded more than expected last month.
China's Shanghai Index up 2.7 percent as Chinese PMI was stronger than expected. U.S. ISM will be released at 10 Am ET. And that's the point: with earnings season just about over, it is economic news that will be the driver for the next couple of months.
Stock futures pointed to a modest rebound ahead of the open Monday after the Dow and the S&P 500 experienced their biggest one-day percentage drops Friday since July 2.
Plus, get calls on earnings, retail, health care and more.
Worries over health care reform have caused the sector to be underowned, but there are still opportunities for investors looking to take advantage of the low prices, said Charles Boorady of Citigroup and Arthur Henderson of Jeffries & Co.
Playing the volatility of the health care sector while legislation is still pending in Congress could be profitable, especially in managed care, Les Funtleyder, health care strategist at Miller Tabak, told CNBC.
Plus, a play on the cap-and-trade bill.
That's the reason this group recently took such a big a hit, Cramer says.
Markets opened and remained lower on Monday as traders took a breather from the previous week’s stock rally. What's next? Dan Deighan, founder of Deighan Financial Advisors and Michael Yoshikami, chief investment strategist at YCMNET Advisors, shared their market views.
The government is investigating a major insurance company for allegedly trying to scare seniors about the health care overhaul in Congress.
The day after President Obama’s impassioned speech for big-government health care, Wall Street bet heavily that the so-called government-insurance option he supports is dead.
Shares of U.S. health insurers climbed as analysts said Pres. Barack Obama's highly anticipated speech urging Congress to act on health reform revealed no "game changers." Thomas Carroll, analyst at Stifel Nicolaus, and David Joy, chief market strategist at RiverSource Investments, shared their insights on the industry.
As the health care debate continues, Todd Weller, health care IT analyst at Stifel Nicolaus, and Les Funtleyder, health care strategist at Miller Tabak, zero in on health care names that may bring healthy returns.